Authors' response
- 1Centre for Respiratory Research, University College London, London, UK
- 2Respiratory Medicine, Imperial College Healthcare NHS Trust, London, UK
- Correspondence to Dr Neal Navani, Department of Thoracic Medicine, University College London Hospital, 250 Euston Road, London NW1 2PG, UK; neal.navani{at}uclh.nhs.uk
-
Contributors This reply was drafted by NN and modified and approved by the co-authors.
- Accepted 24 October 2011
- Published Online First 16 November 2011
- Bronchoscopy
- lung cancer
- lung cancer chemotherapy
- mesothelioma
- non-small cell lung cancer
- small cell lung cancer
- thoracic surgery
- asthma
- asthma pharmacology
- atypical mycobacterial infection
- COPD pharmacology
- opportunist lung infections
- tobacco and the lung
- tuberculosis
We thank Dr Tournoy for his interest in our article on the utility of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for the diagnosis of tuberculous intrathoracic lymphadenopathy.1
With regard to the patient selection in our study, we have acknowledged in the Discussion that the characteristics of patients with intrathoracic lymph node tuberculosis not submitted for EBUS-TBNA are unknown. This selection bias is an inherent problem in retrospective cohort studies, as only those patients suitable for EBUS-TBNA are included. Dr Tournoy would like to know the sensitivity of EBUS-TBNA …
